Elif Birtaş Ateşoğlu

Soluble Programmed Death 1 (PD-1) Is Decreased in Patients With Immune Thrombocytopenia (ITP)

Elif Birtaş Ateşoğlu, Pınar Tarkun, Esra Terzi Demirsoy et al. · Clinical and Applied Thrombosis/Hemostasis · 2014 · 33 citations · Full text

Clinical Immunology, T-regulatory Cell, Immunology +18

Glofitamab in relapsed/refractory diffuse large B‐cell lymphoma: Real‐world data

Elif Birtaş Ateşoğlu, Zafer Gülbaş, Ant Uzay et al. · Hematological Oncology · 2023 · 25 citations · Full text

Cell Therapy, Immunology, Pathology +16

Serum hepcidin and growth differentiation factor‐15 (<scp>GDF</scp>‐15) levels in polycythemia vera and essential thrombocythemia

Pınar Tarkun, Özgür Mehtap, Elif Birtaş Ateşoğlu et al. · European Journal Of Haematology · 2013 · 24 citations

Azacitidine has limited activity in ‘real life’ patients with MDS and AML: a single centre experience

Murat Özbalak, Mustafa Çeti̇ner, Hüseyin Saffet Beköz et al. · Hematological Oncology · 2011 · 22 citations

Serum Growth Differentiation Factor 15 Levels in Newly Diagnosed Multiple Myeloma Patients

Pınar Tarkun, Elif Birtaş Ateşoğlu, Özgür Mehtap et al. · Acta Haematologica · 2013 · 19 citations